CPE
CITIC Private Equity Funds Management is the strategic onshore private equity platform of CITIC Group and CITIC.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed CPE Information
Geographic Data
Address: 11/F Jinbao Tower
City: Dongcheng District
State: beijing municipality
Zip: 100005
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
CPE is a leading alternative asset manager, with asset classes spanning private equity, mezzanine and the public market. Founded in 2008 by a world class team of investment professionals and supported by over 200 domestic and international investors, CPE knows China like no one else and is a globally minded long-term value investor. The firm uses its sector expertise to generate deal flow and drive the value creation work during the post-investment stage. CPE follows a disciplined investment approach to preserve and grow its investors’ capital. The firm’s private equity portfolio of more than 100 companies is highly diversified by sector and stage of investment. CPE takes pride in its forward-looking investment philosophy and works hard to create value over the long-term for its investors and a better world. For more information, please visit www.citicpe.com.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2021 | GTA Semiconductor | Venture Round | 0 |
| 3/2022 | XVERSE | Series A | 120M |
| 9/2020 | Fiture | Series A | 0 |
| 3/2021 | Kunlun | Venture Round | - |
| 2/2021 | Wangjiahuan | Series B | 123.8M |
| 9/2013 | G-NET | Angel Round | 489.6k |
| 11/2021 | Ustar | Series E | 47.1M |
| 3/2021 | ThreatBook | Series E | 76.9M |
| 4/2020 | MicroPort CardioFlow | Private Equity Round | 130M |
| 6/2011 | New China Life Insurance | Venture Round | - |
| 11/2009 | China UnionPay Merchant Services | Series C | - |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 6/2015 | Touch | Series B | 13.7M |
| 4/2021 | Shumei Technology | Series D | 135M |
| 5/2021 | Weilong Foods | Series A | 558M |
| 5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 154.9M |
| 7/2021 | TransThera Biosciences | Series D | 100M |
| 1/2021 | Horizon Robotics | Series C | 0 |
| 2/2021 | Shanghai ANE Logistics | Private Equity Round | 300M |
| 8/2021 | JOINN Biologics | Series B | 150M |
| 12/2020 | Lumous Intelligence | Series A | - |
| 4/2021 | Fiture | Series B | 0 |
| 9/2016 | Best | Private Equity Round | 0 |
| 1/2010 | Red Star Macalline | Private Equity Round | 380.7M |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 3/2021 | Biotheus | Equity | 100M |
| 7/2017 | Terminus Technologies | Series A | 73.5M |
| 8/2020 | MicroPort EP | Private Equity Round | 43.1M |
| 10/2021 | Wangdiantong | Series D | 312M |
| 1/2021 | Geek+ | Series D | - |
| 10/2020 | Yuanfudao | Series G | 0 |
| 1/2015 | ELEME | Series E | 350M |
| 6/2020 | JW Therapeutics | Series B | 0 |
| 7/2021 | Synlight Crystal | Series E | - |
| 12/2021 | Chipone Technology | Series E | 0 |
| 5/2019 | Chuangmi Technology | Series A | 0 |
| 4/2022 | Reliable Med | Series A | 15M |
| 9/2010 | Shaanxi Xifeng Liquor Co,.LTD | Angel Round | 448.3k |
| 9/2021 | HiScene | Series C | 0 |
| 6/2021 | Biocytogen | Series E | - |
| 9/2020 | DuerOS | Series A | 294.5M |
| 6/2021 | Banu Hotpot | Venture Round | 77.3M |
| 3/2021 | Biotheus | Series B | - |
| 3/2019 | Servyou Group | Angel Round | 446.9k |
| 1/2021 | Jaka Robot | Series C | 46.3M |
| 2/2021 | Pony.ai | Series C | 0 |
| 8/2020 | Hanyu Medical | Series D | 0 |
| 2/2021 | Fenbi | Series A | 390M |
| 9/2020 | MicroPort Medbot | Private Equity Round | 512.4M |
| 1/2021 | Didi Woya | Series A | 0 |
| 1/2016 | Fengbang Leasing | Series D | 45.7M |
| 9/2011 | Green A | Series B | 15.7M |
| 1/2021 | Mixuebingcheng | Series A | 309.2M |
| 10/2016 | ofo | Series C | 130M |
| 7/2017 | ofo | Series E | 700M |
| 5/2021 | MissBerry Berry Sweetheart | Series A | 0 |
| 6/2021 | Triastek | Series B | 0 |
| 10/2021 | Dreame Technology | Series C | 0 |
| 5/2018 | CStone Pharmaceuticals | Series B | 260M |
| 5/2021 | Opnous | Series B | - |
| 2/2021 | Didi Freight | Series A | 0 |
| 7/2011 | VANCL | Series F | 230M |
| 1/2021 | Enflame | Series C | 278.8M |
| 9/2021 | MissBerry Berry Sweetheart | Venture Round | 1.6M |
| 9/2016 | guanaitong.com | Private Equity Round | 20.2M |
| 10/2020 | 3D Medicines | Private Equity Round | 0 |
| 1/2021 | 4Paradigm | Series D | 0 |
| 8/2022 | Jinyuansheng | Series B | 147.6M |
| 6/2018 | Deerma | Series A | 76.5M |
| 12/2018 | Adaps Photonics | Angel Round | 431.1k |
| 2/2014 | Cheyipai | Series C | 50M |
| 1/2022 | SiBionics | Series C | 0 |
| 1/2010 | CHINA UNION LOYALTY | Series A | 2.9M |
| 4/2015 | ZHONGHE PHARMACEUTICAL | Funding Round | 8.1M |
| 11/2014 | Zhongce Che Kongjian | Series B | 3.2M |
| 3/2018 | 17zuoye | Series E | 250M |
| 5/2019 | JD Health | Series A | 1B |
| 12/2021 | Lumous Intelligence | Series B | - |
| 6/2021 | Hesai Technology | Series D | 300M |
| 11/2021 | Zhihe Technology | Series B | - |
| 3/2017 | ofo | Series D | 450M |
| 3/2016 | FXiaoKe | Series E | - |
| 9/2021 | Mol Breeding | Series A | 1.6M |
| 12/2017 | Jiaanpei | Venture Round | 0 |
| 11/2021 | Hesai Technology | Series D | 70M |
| 4/2010 | Happigo | Series A | 43.9M |
| 5/2021 | Rapid Medical | Series D | 50M |
| 7/2021 | Cloudwise | Series E | 150M |
| 1/2021 | Synlight Crystal | Series C | - |
| 4/2022 | Reliable Med | Series A | 0 |
| 3/2022 | XVERSE | Series A | 0 |
| 1/2022 | SiBionics | Series C | 0 |
| 12/2021 | Lumous Intelligence | Series B | - |
| 12/2021 | Chipone Technology | Series E | 0 |
| 11/2021 | GTA Semiconductor | Venture Round | 0 |
| 11/2021 | Ustar | Series E | 0 |
| 11/2021 | Hesai Technology | Series D | 0 |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 11/2021 | Zhihe Technology | Series B | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
